After treatment with RIF, RIF@PLA‐PEG‐Gd/Mal, RIF@PLA‐PEG‐Gd/Mal‐RVG29, Aβ deposition in the hippocampus and cortex showed a decreasing trend.
← all excerpts
Targeted brain delivery of RVG29-modified rifampicin-loaded nanoparticles for Alzheimer's disease treatment and diagnosis.
1
—
—